EUVIMEDEUVIMED entdecken
Open Access

Pediatric Oncology Clinical Trial Participation Among Families From Historically Marginalized Groups

Puja J Umaretiya, Morgan A Paul, Ariana Valenzuela, Alexandria Hawkins, Anna C Revette, Brett Nava-Coulter, Ijeoma Julie Eche-Ugwu, Jennifer M Snaman, Rahela Aziz-Bose, Colleen A Kelly, Gabriella Nguyen, Sandi L Pruitt und 2 weitere

JAMA Network Open · 31.07.2026 · 9 (7) · e2626538

DOI: 10.1001/jamanetworkopen.2026.26538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 31.07.2026. Verfasst von Puja J Umaretiya und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas. Hauptthemen laut MEDLINE: Clinical Trials as Topic, Neoplasms, Parents, Medical Oncology. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Perspectives of families from historically marginalized groups regarding pediatric oncology clinical trial participation are not well-represented in the literature.

Objective

To describe clinician- and parent-perceived facilitators and barriers to clinical trial participation. Design, Setting, and Participants This single-center cross-sectional study with an explanatory sequential mixed-methods design enrolled parents of Black and Hispanic children with cancer as well as pediatric oncology clinicians from a large pediatric cancer center in Boston, Massachusetts. Parent participants completed single–time point surveys, and a subset, purposively sampled based on self-identified race and ethnicity, language, and household material hardship (HMH; ie, food, housing, transportation, or utility insecurity), completed semistructured interviews from September to December 2021. Clinicians completed semistructured interviews from February to March 2022. Data were analyzed from April 2022 to October 2025. Main Outcomes and Measures Key factors influencing clinical trial participation in pediatric oncology among parents from historically marginalized groups. Quantitative data were summarized descriptively. Interview transcripts were analyzed using thematic analysis and integrated along key domains.

Results

A total of 60 parents completed the questionnaire; self-identified race and ethnicity included 5 Hispanic Black (8%), 10 Hispanic White (17%), 21 Hispanic other (35%), 21 non-Hispanic Black (35%), and 3 non-Hispanic White (5%) parents; most were mothers (51 [85%]). Twenty parents participated in interviews. Fifteen clinicians (10 [67%] female participants; 10 [67%] with ≥10 years caring for children with cancer) were interviewed, including 12 (80%) attendings and 3 (20%) advanced practice practitioners; most identified as non-Hispanic White (14 [93%]). Most families experienced HMH (44 [73%]) and reported high trust in their oncology team (mean [SD] score, 4.63 [0.65] of 5.00). Qualitatively, parents and clinicians aligned in identifying altruism and trustworthiness as facilitators to trial participation, while the informed consent discussion, non-English language preference, trial materials, and study requirements were participation barriers. Unlike clinicians, parents did not identify HMH or the experimental nature of trials as significant barriers to participation. Parents identified the desire for representation as a facilitator to participation, and clinicians identified gatekeeping as a barrier. Conclusions and Relevance In this cross-sectional study of pediatric oncology families from historically marginalized groups and clinicians, clinician- and parent-perceived barriers identified opportunities to increase equitable trial participation. Next steps include standardization of trial eligibility screening and systematic HMH screening and support to reduce gatekeeping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical Trials as TopicNeoplasmsParentsMedical OncologyPatient ParticipationHumansCross-Sectional StudiesFemaleMaleChildHispanic or LatinoBlack or African AmericanBostonAdultSurveys and QuestionnairesPediatricsAdolescentChild, Preschool

Autor:innen und Institutionen

  • Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas.
  • Department of Social and Behavioral Sciences, Peter O'Donnell Jr School of Public Health, University of Texas Southwestern Medical Center, Dallas.
  • Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas.
  • Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Division of Pediatric Intensive Care, Children's Hospital Colorado, Aurora.
  • University of Miami Leonard M. Miller School of Medicine, Miami, Florida.

Förderung

  • NCI NIH HHS

Zitieren

APA

Umaretiya, P. J., Paul, M. A., Valenzuela, A., Hawkins, A., Revette, A. C., Nava-Coulter, B., Eche-Ugwu, I. J., Snaman, J. M., Aziz-Bose, R., Kelly, C. A., Nguyen, G., Pruitt, S. L., Wolfe, J., & Bona, K. (2026). Pediatric Oncology Clinical Trial Participation Among Families From Historically Marginalized Groups. JAMA Network Open, 9(7), e2626538. https://doi.org/10.1001/jamanetworkopen.2026.26538

Vancouver

Umaretiya PJ, Paul MA, Valenzuela A, Hawkins A, Revette AC, Nava-Coulter B, et al. Pediatric Oncology Clinical Trial Participation Among Families From Historically Marginalized Groups. JAMA Network Open. 2026;9(7):e2626538. doi:10.1001/jamanetworkopen.2026.26538

BibTeX
@article{Umaretiya2026,
  author = {Umaretiya, Puja J and Paul, Morgan A and Valenzuela, Ariana and Hawkins, Alexandria and Revette, Anna C and Nava-Coulter, Brett and Eche-Ugwu, Ijeoma Julie and Snaman, Jennifer M and Aziz-Bose, Rahela and Kelly, Colleen A and Nguyen, Gabriella and Pruitt, Sandi L and Wolfe, Joanne and Bona, Kira},
  title = {Pediatric Oncology Clinical Trial Participation Among Families From Historically Marginalized Groups},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {7},
  pages = {e2626538},
  doi = {10.1001/jamanetworkopen.2026.26538}
}
Kostenlos starten →